Cargando…
Microorganisms with Claimed Probiotic Properties: An Overview of Recent Literature
Probiotics are defined as live microorganisms, which when administered in adequate amounts, confer a health benefit on the host. Health benefits have mainly been demonstrated for specific probiotic strains of the following genera: Lactobacillus, Bifidobacterium, Saccharomyces, Enterococcus, Streptoc...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053917/ https://www.ncbi.nlm.nih.gov/pubmed/24859749 http://dx.doi.org/10.3390/ijerph110504745 |
_version_ | 1782320467301892096 |
---|---|
author | Fijan, Sabina |
author_facet | Fijan, Sabina |
author_sort | Fijan, Sabina |
collection | PubMed |
description | Probiotics are defined as live microorganisms, which when administered in adequate amounts, confer a health benefit on the host. Health benefits have mainly been demonstrated for specific probiotic strains of the following genera: Lactobacillus, Bifidobacterium, Saccharomyces, Enterococcus, Streptococcus, Pediococcus, Leuconostoc, Bacillus, Escherichia coli. The human microbiota is getting a lot of attention today and research has already demonstrated that alteration of this microbiota may have far-reaching consequences. One of the possible routes for correcting dysbiosis is by consuming probiotics. The credibility of specific health claims of probiotics and their safety must be established through science-based clinical studies. This overview summarizes the most commonly used probiotic microorganisms and their demonstrated health claims. As probiotic properties have been shown to be strain specific, accurate identification of particular strains is also very important. On the other hand, it is also demonstrated that the use of various probiotics for immunocompromised patients or patients with a leaky gut has also yielded infections, sepsis, fungemia, bacteraemia. Although the vast majority of probiotics that are used today are generally regarded as safe and beneficial for healthy individuals, caution in selecting and monitoring of probiotics for patients is needed and complete consideration of risk-benefit ratio before prescribing is recommended. |
format | Online Article Text |
id | pubmed-4053917 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-40539172014-06-12 Microorganisms with Claimed Probiotic Properties: An Overview of Recent Literature Fijan, Sabina Int J Environ Res Public Health Review Probiotics are defined as live microorganisms, which when administered in adequate amounts, confer a health benefit on the host. Health benefits have mainly been demonstrated for specific probiotic strains of the following genera: Lactobacillus, Bifidobacterium, Saccharomyces, Enterococcus, Streptococcus, Pediococcus, Leuconostoc, Bacillus, Escherichia coli. The human microbiota is getting a lot of attention today and research has already demonstrated that alteration of this microbiota may have far-reaching consequences. One of the possible routes for correcting dysbiosis is by consuming probiotics. The credibility of specific health claims of probiotics and their safety must be established through science-based clinical studies. This overview summarizes the most commonly used probiotic microorganisms and their demonstrated health claims. As probiotic properties have been shown to be strain specific, accurate identification of particular strains is also very important. On the other hand, it is also demonstrated that the use of various probiotics for immunocompromised patients or patients with a leaky gut has also yielded infections, sepsis, fungemia, bacteraemia. Although the vast majority of probiotics that are used today are generally regarded as safe and beneficial for healthy individuals, caution in selecting and monitoring of probiotics for patients is needed and complete consideration of risk-benefit ratio before prescribing is recommended. MDPI 2014-05-05 2014-05 /pmc/articles/PMC4053917/ /pubmed/24859749 http://dx.doi.org/10.3390/ijerph110504745 Text en © 2014 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). |
spellingShingle | Review Fijan, Sabina Microorganisms with Claimed Probiotic Properties: An Overview of Recent Literature |
title | Microorganisms with Claimed Probiotic Properties: An Overview of Recent Literature |
title_full | Microorganisms with Claimed Probiotic Properties: An Overview of Recent Literature |
title_fullStr | Microorganisms with Claimed Probiotic Properties: An Overview of Recent Literature |
title_full_unstemmed | Microorganisms with Claimed Probiotic Properties: An Overview of Recent Literature |
title_short | Microorganisms with Claimed Probiotic Properties: An Overview of Recent Literature |
title_sort | microorganisms with claimed probiotic properties: an overview of recent literature |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053917/ https://www.ncbi.nlm.nih.gov/pubmed/24859749 http://dx.doi.org/10.3390/ijerph110504745 |
work_keys_str_mv | AT fijansabina microorganismswithclaimedprobioticpropertiesanoverviewofrecentliterature |